Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (2 Iodo 2 aryl) ethyl aryl ether. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110015981B details a novel CuI-catalyzed three-component reaction for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable manufacturing.